CSCRX | VSGAX | CSCRX / VSGAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 13 years | - |
Gain YTD | 24.327 | 16.259 | 150% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.36B | 35.8B | 7% |
Annual Yield % from dividends | 0.00 | 0.66 | - |
Returns for 1 year | 40.14 | 32.36 | 124% |
Returns for 3 years | -19.04 | -6.65 | 286% |
Returns for 5 years | 33.15 | 47.65 | 70% |
Returns for 10 years | -2.58 | 131.60 | -2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BPTIX | 187.90 | 0.74 | +0.40% |
Baron Partners Institutional | |||
KSOAX | 191.39 | 0.10 | +0.05% |
Kinetics Small Cap Opportunities Adv A | |||
IUAEX | 24.98 | -0.19 | -0.75% |
JPMorgan International Focus A | |||
SBHIX | 24.16 | -0.59 | -2.38% |
Saratoga Health & Biotechnology I | |||
ULPSX | 104.34 | -2.83 | -2.64% |
ProFunds UltraBull Svc |